Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity

C. H. Chen, K. C. Lin, D. T Y Yu, C. Yang, F. Huang, H. A. Chen, T. H. Liang, H. T. Liao, C. Y. Tsai, J. C C Wei, C. T. Chou

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Objective. To submit serum levels of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) to statistical analyses to test their exact degrees of clinical usefulness as biomarkers for detecting high disease activity in ankylosing spondylitis (AS), comparing them with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Methods. Serum levels of MMP-1, -3, -9 and TI MP-1 and -2 were measured in 42 AS patients and 20 healthy controls. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) provided the gold standard for measuring disease activity. Patients with BASDAI ≥4 were regarded as having high disease activity. The results were compared with results for a separate cohort of 41 AS patients. Results. Only MMP-3 levels were significantly higher in AS patients than in healthy controls (P

Original languageEnglish
Pages (from-to)414-420
Number of pages7
JournalRheumatology
Volume45
Issue number4
DOIs
Publication statusPublished - Apr 2006
Externally publishedYes

Fingerprint

Tissue Inhibitor of Metalloproteinases
Matrix Metalloproteinase 3
Matrix Metalloproteinase Inhibitors
Ankylosing Spondylitis
Biomarkers
Serum
Baths
Matrix Metalloproteinase 1
Blood Sedimentation
C-Reactive Protein

Keywords

  • Ankylosing spondylitis
  • Disease activity
  • Matrix metalloproteinase
  • Tissue inhibitors of metalloproteinase

ASJC Scopus subject areas

  • Neuroscience(all)
  • Rheumatology

Cite this

Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis : MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. / Chen, C. H.; Lin, K. C.; Yu, D. T Y; Yang, C.; Huang, F.; Chen, H. A.; Liang, T. H.; Liao, H. T.; Tsai, C. Y.; Wei, J. C C; Chou, C. T.

In: Rheumatology, Vol. 45, No. 4, 04.2006, p. 414-420.

Research output: Contribution to journalArticle

Chen, C. H. ; Lin, K. C. ; Yu, D. T Y ; Yang, C. ; Huang, F. ; Chen, H. A. ; Liang, T. H. ; Liao, H. T. ; Tsai, C. Y. ; Wei, J. C C ; Chou, C. T. / Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis : MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. In: Rheumatology. 2006 ; Vol. 45, No. 4. pp. 414-420.
@article{1bdbadc7eabe466ebf4a6ea04bcfc107,
title = "Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity",
abstract = "Objective. To submit serum levels of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) to statistical analyses to test their exact degrees of clinical usefulness as biomarkers for detecting high disease activity in ankylosing spondylitis (AS), comparing them with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Methods. Serum levels of MMP-1, -3, -9 and TI MP-1 and -2 were measured in 42 AS patients and 20 healthy controls. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) provided the gold standard for measuring disease activity. Patients with BASDAI ≥4 were regarded as having high disease activity. The results were compared with results for a separate cohort of 41 AS patients. Results. Only MMP-3 levels were significantly higher in AS patients than in healthy controls (P",
keywords = "Ankylosing spondylitis, Disease activity, Matrix metalloproteinase, Tissue inhibitors of metalloproteinase",
author = "Chen, {C. H.} and Lin, {K. C.} and Yu, {D. T Y} and C. Yang and F. Huang and Chen, {H. A.} and Liang, {T. H.} and Liao, {H. T.} and Tsai, {C. Y.} and Wei, {J. C C} and Chou, {C. T.}",
year = "2006",
month = "4",
doi = "10.1093/rheumatology/kei208",
language = "English",
volume = "45",
pages = "414--420",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis

T2 - MMP-3 is a reproducibly sensitive and specific biomarker of disease activity

AU - Chen, C. H.

AU - Lin, K. C.

AU - Yu, D. T Y

AU - Yang, C.

AU - Huang, F.

AU - Chen, H. A.

AU - Liang, T. H.

AU - Liao, H. T.

AU - Tsai, C. Y.

AU - Wei, J. C C

AU - Chou, C. T.

PY - 2006/4

Y1 - 2006/4

N2 - Objective. To submit serum levels of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) to statistical analyses to test their exact degrees of clinical usefulness as biomarkers for detecting high disease activity in ankylosing spondylitis (AS), comparing them with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Methods. Serum levels of MMP-1, -3, -9 and TI MP-1 and -2 were measured in 42 AS patients and 20 healthy controls. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) provided the gold standard for measuring disease activity. Patients with BASDAI ≥4 were regarded as having high disease activity. The results were compared with results for a separate cohort of 41 AS patients. Results. Only MMP-3 levels were significantly higher in AS patients than in healthy controls (P

AB - Objective. To submit serum levels of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) to statistical analyses to test their exact degrees of clinical usefulness as biomarkers for detecting high disease activity in ankylosing spondylitis (AS), comparing them with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Methods. Serum levels of MMP-1, -3, -9 and TI MP-1 and -2 were measured in 42 AS patients and 20 healthy controls. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) provided the gold standard for measuring disease activity. Patients with BASDAI ≥4 were regarded as having high disease activity. The results were compared with results for a separate cohort of 41 AS patients. Results. Only MMP-3 levels were significantly higher in AS patients than in healthy controls (P

KW - Ankylosing spondylitis

KW - Disease activity

KW - Matrix metalloproteinase

KW - Tissue inhibitors of metalloproteinase

UR - http://www.scopus.com/inward/record.url?scp=33645303237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645303237&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kei208

DO - 10.1093/rheumatology/kei208

M3 - Article

C2 - 16287916

AN - SCOPUS:33645303237

VL - 45

SP - 414

EP - 420

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 4

ER -